STOK
Stoke Therapeutics (STOK)
$
60About Stoke Therapeutics (STOK)
Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.
Details
Daily high
$8.72
Daily low
$8.18
Price at open
$8.18
52 Week High
$17.58
52 Week Low
$5.60
Market cap
455.5M
Dividend yield
0.00%
Volume
876,956
Avg. volume
770,946
P/E ratio
-4.10
Stoke Therapeutics News
Details
Daily high
$8.72
Daily low
$8.18
Price at open
$8.18
52 Week High
$17.58
52 Week Low
$5.60
Market cap
455.5M
Dividend yield
0.00%
Volume
876,956
Avg. volume
770,946
P/E ratio
-4.10